Mizuho Says Synthetic Biologics IBS Treatment May Be 'Interesting' For Valeant
June 29, 2018 at 16:13 PM EDT
Mizuho analyst Irina Koffler raised her price target for Valeant Pharmaceuticals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.